Developer docs
API playgroundTry for free, no card

Search company profiles

CUP Contract Labs

Full company profile

uuid00482oz

Namestring
CUP Contract Labs
Legal namestring
CUP Laboratorien Dr. Freitag GmbH
Company typeenum
Private
Founded yearint
2008
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRadeberg, Germany
HQ citystring
Radeberg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract laboratory services, pharmaceutical analytical testing, radiopharmaceutical analysis, GMP quality control, sterility testing services
Industry3 codes
PRIMARYHLAGADAC
Release Testing & Batch Certification (QC)
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Contract Laboratory Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Analytical Testing Services
TypeProfessional Services
Description

Contract laboratory providing GMP-compliant pharmaceutical analysis services including sterility testing, particle analysis, radiolabeling development, extractables/leachables studies, nitrosamine analysis, and stability testing. Revenue generated through service contracts and project-based testing.

cup-contract-labs.com
2Method Development and Validation
TypeProfessional Services
Description

Product-specific analytical and process validations including sterility testing validation for automated systems. Supports regulatory compliance and dossier submissions across development stages.

cup-contract-labs.com
3GMP Quality Control and Release Testing
TypeProfessional Services
Description

Quality control services for batch release of sterile products including in-process control and release analysis for radioactive and classical products.

cup-contract-labs.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Custom service-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing varies based on service requirements, product complexity, and testing scope. Quotes are created and tracked through Proposify.

cup-contract-labs.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1RADIOSTER
Description

Specialized radioactive analysis service for radiopharmaceuticals, including microbiology and analytical chemistry services.

cup-contract-labs.com
Core offering1 text field

CUP Contract Labs is a contract laboratory providing GMP/FDA-compliant pharmaceutical analytical services from development through quality control and release testing. The company specializes in complex pharmaceuticals including radiopharmaceuticals, biologics, vaccines, high-potency drugs, orphan drugs, and targeted therapeutics, offering sterility testing, radiolabeling development, extractables/leachables studies, nitrosamines analysis, and stability testing under a one-stop-shop model.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CUP Contract Labs is a contract laboratory and strategic partner providing comprehensive pharmaceutical analysis services from development through quality control and regulatory approval. Their portfolio includes RADIOSTER (their branded radiopharmaceutical analysis service), sterility testing, radiolabeling development, nitrosamines analysis, extractables and leachables studies, stability testing, and analytical services for biologics, vaccines, radiopharmaceuticals, high potent drugs, targeted therapeutics, orphan drugs, and other complex pharmaceuticals. They operate analytical methods including HPLC, LC-MS/MS, GC/GC-MS, ICP-MS, and Radio-TLC, all performed under GMP/FDA standards. The company offers these services as an integrated one-stop-shop concept, supporting clients from initial analysis through final product release.

Product and service11 records
1RADIOSTER - Radioactive Analysis
CategoryRadiopharmaceutical Contract Laboratory Service
Description

Specific analysis in the field of microbiology and analytical chemistry for radiopharmaceuticals, including GMP quality control and release testing services, designed for pharmaceutical manufacturers of radioactive products.

2Sterility Testing & Validation for Radiopharmaceuticals
CategoryMicrobiological Quality Control Service
Description

Sterility testing using membrane filtration in compliance with Ph. Eur. 2.6.1 and USP <71>, suitable for products with short half-lives and high activity levels under GMP conditions, including sterility testing validation for automated systems such as SteriNow (TRASIS).

3MAT for Radiopharmaceuticals
CategoryBiological Quality Control Service
Description

Monocyte Activation Test specifically adapted for radiopharmaceutical products, supporting pyrogen testing under GMP conditions.

4Radiolabeling Development
CategoryRadiopharmaceutical Development Service
Description

Development of radiolabelling for active substances (small molecules, peptides, antibodies) with analytical control of radiochemical purity (RCP), radiochemical yield (RCY), and potential by-products, including full chemical and microbiological quality control to support GMP-compliant product release.

5Hygiene Monitoring
CategoryMicrobiological Quality Control Service
Description

Operational hygiene monitoring services for pharmaceutical manufacturing environments, supporting GMP compliance for cleanroom and production facilities.

6Nitrosamines Analysis
CategoryImpurity Analysis Service
Description

Highly sensitive screening and validated quantification of nitrosamines in APIs, formulations, and materials, with methods that support regulatory risk assessments including challenging matrices.

7Dissolution Testing
CategoryPharmaceutical Quality Control Service
Description

Dissolution testing services for pharmaceutical quality control of solid dosage forms.

8Visible & Subvisible Particles Analysis
CategoryPharmaceutical Quality Control Service
Description

Determination of visible and sub-visible particles to ensure compliance with particle-related quality requirements and support batch release of sterile products.

9Extractables and Leachables (E&L) Studies
CategoryPharmaceutical Safety Assessment Service
Description

Assessment of extractables and leachables from packaging and process contact materials, including impurity profiling and evaluation of potential impact on product safety and stability.

10Stability Testing & Storage
CategoryPharmaceutical Stability Service
Description

Stability studies under defined storage conditions, providing scientific basis for shelf life, storage instructions, and transport conditions under GMP storage requirements.

11Method Development and Validation Services
CategoryAnalytical Method Development Service
Description

Product-specific analytical and process validations, including sterility testing validation for automated systems such as SteriNow (TRASIS), and tailored method development to support regulatory compliance and dossier submissions across development stages.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CUP Contract Labs participates in research projects with HZDR including the RUBIN Alliance SNRT project (Saxon Network for Radionuclide Theranostics) and EU-funded UroNec project. HZDR provides cyclotron facilities and develops radiopharmaceutical candidates such as NECT-224 for bladder cancer imaging. CUP serves as industrial partner contributing analytical expertise to bring radiopharmaceutical research to application.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership for automated sterility testing using SteriNow system. CUP performs sterility testing validation for TRASIS automated systems, which supports regulatory compliance for radiopharmaceutical products. Gauthier Philippart, President & CEO of TRASIS, has publicly discussed the collaboration for innovative solutions in nuclear medicine.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key customer relationship for radiopharmaceutical analytics. Dr. Michael Pröhl, CDMO Manager, has publicly praised CUP as a reliable partner for radiopharmaceutical analytics. The partnership supports release testing and quality control for Eckert & Ziegler radiopharmaceutical products.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key customer relationship for radiopharmaceutical analysis services. Caroline Defraiteur, COO EMEA, has identified CUP as her key contract lab for radiopharmaceutical analyses. The partnership involves ongoing analytical testing and quality control services for Telix radiopharmaceutical products.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Quality control and vaccine analytics partnership. Steffen Schewitzer, Value Creation Implementation Lead at GSK, has praised CUP as a reliable partner for quality control and vaccine analytics, indicating ongoing service relationship for GSK pharmaceutical products.

Strategic tierMinorTypeGTM or Marketing Partner
Description

LinkedIn platform used for promoting webinars and events. CUP receives aggregated anonymized information about content interactions. LinkedIn processes personal data per their own privacy policy when users interact with CUP content.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in testing services with a large pharmaceutical/analytical division that offers release testing, stability, and radiopharmaceutical-adjacent analytical services. Comparable as a major incumbent CRO/lab services competitor against which CUP's specialized radiopharma offering competes for analytical outsourcing spend.

TypeBroad incumbent
Description

CDMO with integrated analytical services including radiolabeling, stability, and release testing. Comparable as a CDMO that bundles analytical services with development and manufacturing, competing for the same radiopharma and complex pharma outsourcing wallet.

TypeBroad incumbent
Description

Pharmaceutical services division of Intertek providing GMP analytical testing, stability, extractables/leachables, and method validation. Directly comparable service portfolio overlap with CUP's QC and validation offerings.

TypeBroad incumbent
Description

Large CRO offering pharmaceutical analytics, biologics testing, and quality control services. Directly comparable as a broad incumbent in GMP analytical testing where CUP competes for outsourced pharma QC projects.

TypeDirect peer
Description

Global radiopharmaceutical company with manufacturing and analytical capabilities. Comparable as a radiopharma specialist whose QC outsourcing and method-development needs overlap directly with CUP's RADIOSTER service line.

TypeDirect peer
Description

Radiopharmaceutical developer and manufacturer with in-house and partner analytical capabilities. Comparable as a radiopharma-focused specialist operating in the same therapeutic/diagnostic modality, representing both a potential partner and competitor for CUP's radiopharma QC services.

TypeEmerging player
Description

Specialized analytical and GMP testing services for biologics and complex therapeutics. Comparable emerging specialized peer for biologics/vaccines testing, where CUP also offers services beyond radiopharmaceuticals.

TypeBroad incumbent
Description

Major CRO providing bioanalytical, central lab, and pharmaceutical development services including QC release testing. Comparable broad incumbent competing for outsourced pharma analytical work.

TypeEmerging player
Description

Provides bioprocess and laboratory products/services to pharma and biologics manufacturers, with growing emphasis on integrated analytical and QC solutions. Comparable as a vendor/partner in the GMP analytical ecosystem where CUP operates.

TypeBroad incumbent
Description

Global testing, inspection and certification company with a dedicated Life Sciences division offering GMP analytical services, stability, and release testing for pharma and biologics. Comparable broad incumbent peer in pharma analytical testing.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CUP Contract Labs

Pharmaceutical Contract Laboratory Servicescup-contract-labs.com

CUP Contract Labs firmographics

Firmographics
Name
CUP Contract Labs
Legal name
CUP Laboratorien Dr. Freitag GmbH
Website
https://cup-contract-labs.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

CUP Contract Labs industry classification

Industry
Product category
Pharmaceutical Contract Laboratory Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGADAC
Release Testing & Batch Certification (QC)
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Contract laboratory services
  • Pharmaceutical analytical testing
  • Radiopharmaceutical analysis
  • GMP quality control
  • Sterility testing services

Where CUP Contract Labs is headquartered

Location

Headquarters

HQ city
Radeberg
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

CUP Contract Labs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Analytical Testing Services: Contract laboratory providing GMP-compliant pharmaceutical analysis services including sterility testing, particle analysis, radiolabeling development, extractables/leachables studies, nitrosamine analysis, and stability testing. Revenue generated through service contracts and project-based testing.
  2. Method Development and Validation: Product-specific analytical and process validations including sterility testing validation for automated systems. Supports regulatory compliance and dossier submissions across development stages.
  3. GMP Quality Control and Release Testing: Quality control services for batch release of sterile products including in-process control and release analysis for radioactive and classical products.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom service-based pricing

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

CUP Contract Labs product offering

Product offering

Core offering

CUP Contract Labs is a contract laboratory providing GMP/FDA-compliant pharmaceutical analytical services from development through quality control and release testing. The company specializes in complex pharmaceuticals including radiopharmaceuticals, biologics, vaccines, high-potency drugs, orphan drugs, and targeted therapeutics, offering sterility testing, radiolabeling development, extractables/leachables studies, nitrosamines analysis, and stability testing under a one-stop-shop model.

Product overview

CUP Contract Labs is a contract laboratory and strategic partner providing comprehensive pharmaceutical analysis services from development through quality control and regulatory approval. Their portfolio includes RADIOSTER (their branded radiopharmaceutical analysis service), sterility testing, radiolabeling development, nitrosamines analysis, extractables and leachables studies, stability testing, and analytical services for biologics, vaccines, radiopharmaceuticals, high potent drugs, targeted therapeutics, orphan drugs, and other complex pharmaceuticals. They operate analytical methods including HPLC, LC-MS/MS, GC/GC-MS, ICP-MS, and Radio-TLC, all performed under GMP/FDA standards. The company offers these services as an integrated one-stop-shop concept, supporting clients from initial analysis through final product release.

Differentiator

Problem solved

Functional benefit

Brands

  • RADIOSTER: Specialized radioactive analysis service for radiopharmaceuticals, including microbiology and analytical chemistry services.

Products and services

  • RADIOSTER - Radioactive Analysis Specific analysis in the field of microbiology and analytical chemistry for radiopharmaceuticals, including GMP quality control and release testing services, designed for pharmaceutical manufacturers of radioactive products.
  • Sterility Testing & Validation for Radiopharmaceuticals Sterility testing using membrane filtration in compliance with Ph. Eur. 2.6.1 and USP <71>, suitable for products with short half-lives and high activity levels under GMP conditions, including sterility testing validation for automated systems such as SteriNow (TRASIS).
  • MAT for Radiopharmaceuticals Monocyte Activation Test specifically adapted for radiopharmaceutical products, supporting pyrogen testing under GMP conditions.
  • Radiolabeling Development Development of radiolabelling for active substances (small molecules, peptides, antibodies) with analytical control of radiochemical purity (RCP), radiochemical yield (RCY), and potential by-products, including full chemical and microbiological quality control to support GMP-compliant product release.
  • Hygiene Monitoring Operational hygiene monitoring services for pharmaceutical manufacturing environments, supporting GMP compliance for cleanroom and production facilities.
  • Nitrosamines Analysis Highly sensitive screening and validated quantification of nitrosamines in APIs, formulations, and materials, with methods that support regulatory risk assessments including challenging matrices.
  • Dissolution Testing Dissolution testing services for pharmaceutical quality control of solid dosage forms.
  • Visible & Subvisible Particles Analysis Determination of visible and sub-visible particles to ensure compliance with particle-related quality requirements and support batch release of sterile products.
  • Extractables and Leachables (E&L) Studies Assessment of extractables and leachables from packaging and process contact materials, including impurity profiling and evaluation of potential impact on product safety and stability.
  • Stability Testing & Storage Stability studies under defined storage conditions, providing scientific basis for shelf life, storage instructions, and transport conditions under GMP storage requirements.
  • Method Development and Validation Services Product-specific analytical and process validations, including sterility testing validation for automated systems such as SteriNow (TRASIS), and tailored method development to support regulatory compliance and dossier submissions across development stages.

Companies that use CUP Contract Labs

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

CUP Contract Labs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

CUP Contract Labs partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Helmholtz Zentrum Dresden Rossendorf (HZDR)coreStrategic or Co-development PartnerCUP Contract Labs participates in research projects with HZDR including the RUBIN Alliance SNRT project (Saxon Network for Radionuclide Theranostics) and EU-funded UroNec project. HZDR provides cyclotron facilities and develops radiopharmaceutical candidates such as NECT-224 for bladder cancer imaging. CUP serves as industrial partner contributing analytical expertise to bring radiopharmaceutical research to application.
  • TRASIScoreTechnology or IntegrationPartnership for automated sterility testing using SteriNow system. CUP performs sterility testing validation for TRASIS automated systems, which supports regulatory compliance for radiopharmaceutical products. Gauthier Philippart, President & CEO of TRASIS, has publicly discussed the collaboration for innovative solutions in nuclear medicine.
  • Eckert & Ziegler Radiopharma GmbHcoreStrategic or Co-development PartnerKey customer relationship for radiopharmaceutical analytics. Dr. Michael Pröhl, CDMO Manager, has publicly praised CUP as a reliable partner for radiopharmaceutical analytics. The partnership supports release testing and quality control for Eckert & Ziegler radiopharmaceutical products.
  • Telix Pharmaceuticals LimitedcoreStrategic or Co-development PartnerKey customer relationship for radiopharmaceutical analysis services. Caroline Defraiteur, COO EMEA, has identified CUP as her key contract lab for radiopharmaceutical analyses. The partnership involves ongoing analytical testing and quality control services for Telix radiopharmaceutical products.
  • GlaxoSmithKline (GSK)coreStrategic or Co-development PartnerQuality control and vaccine analytics partnership. Steffen Schewitzer, Value Creation Implementation Lead at GSK, has praised CUP as a reliable partner for quality control and vaccine analytics, indicating ongoing service relationship for GSK pharmaceutical products.
  • LinkedIn Ireland Unlimited CompanyminorGTM or Marketing PartnerLinkedIn platform used for promoting webinars and events. CUP receives aggregated anonymized information about content interactions. LinkedIn processes personal data per their own privacy policy when users interact with CUP content.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

CUP Contract Labs competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: Global leader in testing services with a large pharmaceutical/analytical division that offers release testing, stability, and radiopharmaceutical-adjacent analytical services. Comparable as a major incumbent CRO/lab services competitor against which CUP's specialized radiopharma offering competes for analytical outsourcing spend.
  • Piramal Pharma Solutions: CDMO with integrated analytical services including radiolabeling, stability, and release testing. Comparable as a CDMO that bundles analytical services with development and manufacturing, competing for the same radiopharma and complex pharma outsourcing wallet.
  • Intertek Pharmaceutical Services: Pharmaceutical services division of Intertek providing GMP analytical testing, stability, extractables/leachables, and method validation. Directly comparable service portfolio overlap with CUP's QC and validation offerings.
  • Charles River Laboratories: Large CRO offering pharmaceutical analytics, biologics testing, and quality control services. Directly comparable as a broad incumbent in GMP analytical testing where CUP competes for outsourced pharma QC projects.
  • Labcorp Drug Development (Fortrea): Major CRO providing bioanalytical, central lab, and pharmaceutical development services including QC release testing. Comparable broad incumbent competing for outsourced pharma analytical work.
  • SGS Life Sciences: Global testing, inspection and certification company with a dedicated Life Sciences division offering GMP analytical services, stability, and release testing for pharma and biologics. Comparable broad incumbent peer in pharma analytical testing.

Direct peers

  • Curium Pharma: Global radiopharmaceutical company with manufacturing and analytical capabilities. Comparable as a radiopharma specialist whose QC outsourcing and method-development needs overlap directly with CUP's RADIOSTER service line.
  • ITM Isotope Technologies Munich: Radiopharmaceutical developer and manufacturer with in-house and partner analytical capabilities. Comparable as a radiopharma-focused specialist operating in the same therapeutic/diagnostic modality, representing both a potential partner and competitor for CUP's radiopharma QC services.

Emerging players

  • Bionova Scientific (part of Asahi Kasei): Specialized analytical and GMP testing services for biologics and complex therapeutics. Comparable emerging specialized peer for biologics/vaccines testing, where CUP also offers services beyond radiopharmaceuticals.
  • Sartorius Lab Products & Services: Provides bioprocess and laboratory products/services to pharma and biologics manufacturers, with growing emphasis on integrated analytical and QC solutions. Comparable as a vendor/partner in the GMP analytical ecosystem where CUP operates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

CUP Contract Labs social profiles

Digital presence

CUP Contract Labs compliance and trust

Trust signal

Compliance4 records

CUP Contract Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CUP Contract Labs leadership team

Management profile

Number of profiles

Profiles6 records

CUP Contract Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CUP Contract Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CUP Contract Labs

What does CUP Contract Labs do?

CUP Contract Labs is a contract laboratory providing GMP/FDA-compliant pharmaceutical analytical services from development through quality control and release testing. The company specializes in complex pharmaceuticals including radiopharmaceuticals, biologics, vaccines, high-potency drugs, orphan drugs, and targeted therapeutics, offering sterility testing, radiolabeling development, extractables/leachables studies, nitrosamines analysis, and stability testing under a one-stop-shop model.

Is CUP Contract Labs a public or private company?

CUP Contract Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was CUP Contract Labs founded?

CUP Contract Labs was founded in 2008. It employs 11 to 50 people.

Where is CUP Contract Labs based?

CUP Contract Labs is headquartered in Radeberg, Germany, in the Europe region.

How does CUP Contract Labs make money?

Three revenue lines are on record. Analytical Testing Services are the primary driver. The others are method Development and Validation and GMP Quality Control and Release Testing.

Who are CUP Contract Labs's main competitors?

Broad incumbents on record are Eurofins Scientific, Piramal Pharma Solutions, Intertek Pharmaceutical Services, Charles River Laboratories, Labcorp Drug Development (Fortrea) and SGS Life Sciences. Direct peers are Curium Pharma and ITM Isotope Technologies Munich. Emerging players are Bionova Scientific (part of Asahi Kasei) and Sartorius Lab Products & Services.

Does CUP Contract Labs have an API?

No public API is recorded for CUP Contract Labs.

What industry is CUP Contract Labs in?

CUP Contract Labs's product category is Pharmaceutical Contract Laboratory Services. Its primary akta.pro industry code is HLAGADAC, Release Testing & Batch Certification (QC), with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales